Summary

Around the world, the average 1-year mortality rate is 10% for patients with a diagnosis of atrial fibrillation (AF) who present to an emergency department for any reason. AF is a major global disease, most of what is known about the disorder is based on studies conducted in Europe and North America. The baseline results from the Randomized Evaluation of Long-Term Anticoagulation Therapy [RE-LY AF] registry demonstrated important regional variations in risk factors and treatment of AF across 47 countries.